[ad_1]
NEW YORK (dpa-AFX) – New positive news about the corona pandemic fight gave Wall Street a boost on Monday. Positive economic data also ensured a good mood.
The Dow Jones Industrial (Dow Jones 30 Industrial) was unable to sustain its initial gains, but recently claimed a 0.56 percent increase to 29,427.62 points. The US benchmark thus partially offset the decline on Friday. For the market-wide S&P 500, it was up 0.07 percent to 3,560.02 points, while the equally tech-friendly NASDAQ 100 lost 0.64 percent to 11,830.50 points.
The mood of US companies improved significantly in November despite the high number of corona infections, while analysts expected a deterioration. This was confirmed by the purchasing managers index compiled by the research company Markit.
According to a government official, the corona vaccine developed by BioNTech and Pfizer could be available in the US starting December 11 in the event of an emergency approval. The vaccine could be delivered to states within 24 hours of approval by the US FDA, a representative responsible for the US government’s vaccination program told CNN.Biontech’s papers went up in New York up 0.8 percent, while Pfizer shares, initially favorable to the market, fell 1.1 percent.
New York-listed CureVac shares rose more than three percent after the biotech company signed a contract with WACKER CHEMIE to produce a candidate corona vaccine.
With the British-Swedish pharmaceutical company AstraZeneca, another company also submitted data on a corona vaccine. The company announced that the vaccine was averaging 70 percent effective based on interim results from a major testing phase. Unlike the Biontech and Pfizer preparation, Astrazeneca vaccine can be transported and stored in the refrigerator at temperatures of two to eight degrees.
“Even if the overall effectiveness seems a bit lower than with mRNA vaccines, AZD1222 has a huge advantage: it is robust and easy to use, so to speak, the ‘worker bee’ among potentially available Covid-19 vaccines.” the Munich-based company explained. Infectiologist Clemens Wendtner. Axi analyst Stephen Innes called the Astrazeneca news a “big problem.” This would likely allow industrialized countries to immunize most risk groups against lung disease by spring 2021.
Shares of Regeneron (Regeneron Pharmaceuticals) rose 0.2 percent. The company’s antibody cocktail for the treatment of Covid-19 received emergency approval in the United States. This means that it can be used to treat patients twelve years and older who are at risk of developing severe Covid 19 symptoms. However, patients who are in the hospital or need oxygen cannot receive the drug.
At Merck & Co (Merck), the share price fell half a percent after the drugmaker announced that it would take over OncoImmune for $ 425 million in cash. The company has an active ingredient for crown patients with severe infections in clinical trials and recently reported positive data.
Aviation stocks visibly benefited from the new Corona news: While American Airlines was up more than four percent, United Airlines was up 2.8 percent despite plans for a larger capital increase.
FOREIGN EXCHANGE TRADING WITH UP TO LEVER 30 NOW
Trade forex with high leverage and small spreads. With only € 100.00 you can benefit from the effect of € 3,000 in capital.
76.4% of retail investor accounts lose money when trading CFDs with this provider. You need to consider whether you can face the high risk of losing your money.
